Clinical Trial: A prospective, multicenter, randomized controlled study on the combination regimen of reduced-dose versus standard-dose dexamethasone in the treatment of newly diagnosed multiple myeloma (China)

Posted On: 2026-09-10

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized controlled study on the combination regimen of reduced-dose versus standard-dose dexamethasone in the treatment of newly diagnosed multiple myeloma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132070

Registration Time: 2026/09/09

Type: Interventional study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=277293

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective, multicenter, randomized controlled study on the combination regimen of reduced-dose versus standard-dose dexamethasone in the treatment of newly diagnosed multiple myeloma (China)